GREY:DLTNF - Post by User
Comment by
Jordan1203on Jan 13, 2021 2:43pm
170 Views
Post# 32286698
RE:Fundamental Research Dec 2020
RE:Fundamental Research Dec 2020gnote1 wrote: BUY Current Price: $0.56 Fair Value: $1.24 Risk*: 4
Revenue beat our expectations. We are revising our 2020 forecast to $58.66M (previously $52.37M), and 2021 forecast to $75.53M (previously $67.44M). • For Q3 and 2020 (9M), EBITDA was -$3.59M and $3.50M, and net losses were $5.85M
retail cannabis sales segment (up 81% YoY) accounted for 60% of Q3 revenue.
Although it is too early to speculate whether D-Pods will gain traction, we consider D-Pods having the ability to further diversify D9’s revenue stream. For conservatism, we are not adding any potential cash flows from this product line, until we have additional details of the product’s effectiveness.
We believe D9 should focus its expansion on the other two markets due to less competition
Sask and Man
Any mention of vaccine pods? Still no news on it? Revenue beat their expectations and they are revising their estimates... so that means D9 did like 21 million in q4?!?!